Review




Structured Review

Almac Inc gene expression dna microarray dataset
A: Supervised hierarchical clustering displaying the genes significantly modulated between the resistant and sensitive cell lines (52 under‐ and 51 over‐expressed in resistant cell lines) using a cutoff of twofold change on expression and FDR < 0.01. B: Fold difference in gene expression between sensitive and resistant cell lines detected by qRT‐PCR analyses. Seven genes were selected from the list of altered genes for this analysis. The results from sensitive or resistant cell lines were pooled to obtain an estimated fold change. C: Correlation between the qRT‐PCR and the <t>microarray</t> expression data. The fold difference detected by qRT‐PCR between sensitive and resistant cell lines correlated significantly confirming the microarray results (Pearson's correlation or ρ = 0.739, p ‐value = 0.013).
Gene Expression Dna Microarray Dataset, supplied by Almac Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene expression dna microarray dataset/product/Almac Inc
Average 90 stars, based on 1 article reviews
gene expression dna microarray dataset - by Bioz Stars, 2026-03
90/100 stars

Images

1) Product Images from "A 12‐gene signature to distinguish colon cancer patients with better clinical outcome following treatment with 5‐fluorouracil or FOLFIRI"

Article Title: A 12‐gene signature to distinguish colon cancer patients with better clinical outcome following treatment with 5‐fluorouracil or FOLFIRI

Journal: The Journal of Pathology: Clinical Research

doi: 10.1002/cjp2.17

A: Supervised hierarchical clustering displaying the genes significantly modulated between the resistant and sensitive cell lines (52 under‐ and 51 over‐expressed in resistant cell lines) using a cutoff of twofold change on expression and FDR < 0.01. B: Fold difference in gene expression between sensitive and resistant cell lines detected by qRT‐PCR analyses. Seven genes were selected from the list of altered genes for this analysis. The results from sensitive or resistant cell lines were pooled to obtain an estimated fold change. C: Correlation between the qRT‐PCR and the microarray expression data. The fold difference detected by qRT‐PCR between sensitive and resistant cell lines correlated significantly confirming the microarray results (Pearson's correlation or ρ = 0.739, p ‐value = 0.013).
Figure Legend Snippet: A: Supervised hierarchical clustering displaying the genes significantly modulated between the resistant and sensitive cell lines (52 under‐ and 51 over‐expressed in resistant cell lines) using a cutoff of twofold change on expression and FDR < 0.01. B: Fold difference in gene expression between sensitive and resistant cell lines detected by qRT‐PCR analyses. Seven genes were selected from the list of altered genes for this analysis. The results from sensitive or resistant cell lines were pooled to obtain an estimated fold change. C: Correlation between the qRT‐PCR and the microarray expression data. The fold difference detected by qRT‐PCR between sensitive and resistant cell lines correlated significantly confirming the microarray results (Pearson's correlation or ρ = 0.739, p ‐value = 0.013).

Techniques Used: Expressing, Gene Expression, Quantitative RT-PCR, Microarray



Similar Products

90
Biotechnology Information dna microarray gene expression datasets
Workflow of this study. The <t>DNA</t> <t>microarray</t> gene expression datasets of 92 borderline ovarian tumor (BOT) samples and 136 normal ovarian controls were downloaded from a publicly available database with the gene set regularity (GSR) index calculated by the Gene Ontology (GO) gene set. Functionomes consisting of 10,192 GO gene sets established from the polygenic model and machine learning with statistical methods and cumulative portion transformations were used to recognize the functionome patterns to discover dysfunctional GO terms, pathways, and differentially expressed genes (DEGs). Finally, the pathogenesis of BOTs was investigated by integrative analysis.
Dna Microarray Gene Expression Datasets, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna microarray gene expression datasets/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
dna microarray gene expression datasets - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Biotechnology Information moc dna microarray gene expression datasets
Workflow of this study. The <t>DNA</t> <t>microarray</t> gene expression datasets of 92 borderline ovarian tumor (BOT) samples and 136 normal ovarian controls were downloaded from a publicly available database with the gene set regularity (GSR) index calculated by the Gene Ontology (GO) gene set. Functionomes consisting of 10,192 GO gene sets established from the polygenic model and machine learning with statistical methods and cumulative portion transformations were used to recognize the functionome patterns to discover dysfunctional GO terms, pathways, and differentially expressed genes (DEGs). Finally, the pathogenesis of BOTs was investigated by integrative analysis.
Moc Dna Microarray Gene Expression Datasets, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/moc dna microarray gene expression datasets/product/Biotechnology Information
Average 90 stars, based on 1 article reviews
moc dna microarray gene expression datasets - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Almac Inc gene expression dna microarray dataset
A: Supervised hierarchical clustering displaying the genes significantly modulated between the resistant and sensitive cell lines (52 under‐ and 51 over‐expressed in resistant cell lines) using a cutoff of twofold change on expression and FDR < 0.01. B: Fold difference in gene expression between sensitive and resistant cell lines detected by qRT‐PCR analyses. Seven genes were selected from the list of altered genes for this analysis. The results from sensitive or resistant cell lines were pooled to obtain an estimated fold change. C: Correlation between the qRT‐PCR and the <t>microarray</t> expression data. The fold difference detected by qRT‐PCR between sensitive and resistant cell lines correlated significantly confirming the microarray results (Pearson's correlation or ρ = 0.739, p ‐value = 0.013).
Gene Expression Dna Microarray Dataset, supplied by Almac Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene expression dna microarray dataset/product/Almac Inc
Average 90 stars, based on 1 article reviews
gene expression dna microarray dataset - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Workflow of this study. The DNA microarray gene expression datasets of 92 borderline ovarian tumor (BOT) samples and 136 normal ovarian controls were downloaded from a publicly available database with the gene set regularity (GSR) index calculated by the Gene Ontology (GO) gene set. Functionomes consisting of 10,192 GO gene sets established from the polygenic model and machine learning with statistical methods and cumulative portion transformations were used to recognize the functionome patterns to discover dysfunctional GO terms, pathways, and differentially expressed genes (DEGs). Finally, the pathogenesis of BOTs was investigated by integrative analysis.

Journal: International Journal of Molecular Sciences

Article Title: Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics

doi: 10.3390/ijms22084105

Figure Lengend Snippet: Workflow of this study. The DNA microarray gene expression datasets of 92 borderline ovarian tumor (BOT) samples and 136 normal ovarian controls were downloaded from a publicly available database with the gene set regularity (GSR) index calculated by the Gene Ontology (GO) gene set. Functionomes consisting of 10,192 GO gene sets established from the polygenic model and machine learning with statistical methods and cumulative portion transformations were used to recognize the functionome patterns to discover dysfunctional GO terms, pathways, and differentially expressed genes (DEGs). Finally, the pathogenesis of BOTs was investigated by integrative analysis.

Article Snippet: DNA microarray gene expression datasets were downloaded from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database, and the sample data were obtained from 28 dataset series containing six different DNA microarray platforms without any missing data.

Techniques: Microarray, Gene Expression

A: Supervised hierarchical clustering displaying the genes significantly modulated between the resistant and sensitive cell lines (52 under‐ and 51 over‐expressed in resistant cell lines) using a cutoff of twofold change on expression and FDR < 0.01. B: Fold difference in gene expression between sensitive and resistant cell lines detected by qRT‐PCR analyses. Seven genes were selected from the list of altered genes for this analysis. The results from sensitive or resistant cell lines were pooled to obtain an estimated fold change. C: Correlation between the qRT‐PCR and the microarray expression data. The fold difference detected by qRT‐PCR between sensitive and resistant cell lines correlated significantly confirming the microarray results (Pearson's correlation or ρ = 0.739, p ‐value = 0.013).

Journal: The Journal of Pathology: Clinical Research

Article Title: A 12‐gene signature to distinguish colon cancer patients with better clinical outcome following treatment with 5‐fluorouracil or FOLFIRI

doi: 10.1002/cjp2.17

Figure Lengend Snippet: A: Supervised hierarchical clustering displaying the genes significantly modulated between the resistant and sensitive cell lines (52 under‐ and 51 over‐expressed in resistant cell lines) using a cutoff of twofold change on expression and FDR < 0.01. B: Fold difference in gene expression between sensitive and resistant cell lines detected by qRT‐PCR analyses. Seven genes were selected from the list of altered genes for this analysis. The results from sensitive or resistant cell lines were pooled to obtain an estimated fold change. C: Correlation between the qRT‐PCR and the microarray expression data. The fold difference detected by qRT‐PCR between sensitive and resistant cell lines correlated significantly confirming the microarray results (Pearson's correlation or ρ = 0.739, p ‐value = 0.013).

Article Snippet: Hence, we used a publically available gene expression DNA microarray dataset generated by Almac Diagnostics on 359 FFPE tissue specimens from stage II colon cancer that did not receive adjuvant chemotherapy.

Techniques: Expressing, Gene Expression, Quantitative RT-PCR, Microarray